Nombre del producto:7-Bromo-2-chloroquinoxaline

IUPAC Name:7-bromo-2-chloroquinoxaline

CAS:89891-65-6
Fórmula molecular:C8H4BrClN2
Pureza:97%
Número de catálogo:CM121550
Peso molecular:243.49

Unidad de embalaje Stock disponible Precio($) Cantidad
CM121550-10g in stock ȡƿ
CM121550-25g in stock ũȺ
CM121550-100g in stock ƛǶƥ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :89891-65-6
Fórmula molecular:C8H4BrClN2
Punto de fusión:-
Código de sonrisas:ClC1=NC2=CC(Br)=CC=C2N=C1
Densidad:
Número de catálogo:CM121550
Peso molecular:243.49
Punto de ebullición:
Nº Mdl:MFCD02955309
Almacenamiento:Store at 2-8°C.

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos

Erdafitinib
The Janssen Pharmaceutical Companies of Johnson & Johnson announced on September 8, 2023, that it had submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) to seek approval of Erdafitinib for the treatment of adult patients with locally advanced unresectable or metastatic urothelial carcinoma (UC), harbouring susceptible fibroblast growth factor receptor 3 (FGFR3) genetic alterations, with disease progression during or following at least one line of therapy containing a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-[L]1) inhibitor.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products